<code id='12D0098ACF'></code><style id='12D0098ACF'></style>
    • <acronym id='12D0098ACF'></acronym>
      <center id='12D0098ACF'><center id='12D0098ACF'><tfoot id='12D0098ACF'></tfoot></center><abbr id='12D0098ACF'><dir id='12D0098ACF'><tfoot id='12D0098ACF'></tfoot><noframes id='12D0098ACF'>

    • <optgroup id='12D0098ACF'><strike id='12D0098ACF'><sup id='12D0098ACF'></sup></strike><code id='12D0098ACF'></code></optgroup>
        1. <b id='12D0098ACF'><label id='12D0098ACF'><select id='12D0098ACF'><dt id='12D0098ACF'><span id='12D0098ACF'></span></dt></select></label></b><u id='12D0098ACF'></u>
          <i id='12D0098ACF'><strike id='12D0098ACF'><tt id='12D0098ACF'><pre id='12D0098ACF'></pre></tt></strike></i>

          Home / fashion / comprehensive

          comprehensive


          comprehensive

          author:explore    Page View:27
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In